Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients
Status:
Terminated
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
There is no proven effective treatment for chronic diarrhea caused by the parasite
Cryptosporidium in advanced AIDS. This trial will test the safety of interleukin-12 (IL-12)
as part of a combination therapy for this parasite.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)